Dr. Kevin R. Kelly, MD

  • Los Angeles, CA
  • Hematologist and oncologist
NPI1093963712PAC ID5395890990
Medicare services, 2024
493
Medicare patients, 2024
147
Part D claims, 2024
271
Publications
26
Clinical trials
3
Practice address
1441 Eastlake Ave, Los Angeles, CA
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

USC Norris Cancer Hospital

Los Angeles, California

See all 4 affiliations

Find Dr. Kelly's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kevin R. Kelly is a hematologist and oncologist in Los Angeles, California

Dr. Kelly practices at USC Norris Cancer Hospital in Los Angeles, California.

Dr. Kelly's NPI, 1093963712, was assigned on September 6, 2008. Dr. Kelly graduated from University College Cork Faculty of Medicine in 2001. Dr. Kelly holds California license A143303.

NPI and contact details
Medicare PAC ID
5395890990
NPI enumeration date
September 6, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
51
Medical school graduation
2001

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kevin R. Kelly practices at USC Norris Cancer Hospital in Los Angeles, California

Dr. Kelly's primary practice is USC Norris Cancer Hospital, at 1441 Eastlake Ave, Los Angeles, CA.

  • USC Norris Cancer Hospital
    1441 Eastlake Ave, Los Angeles, CA

Source: Dmand AI Affiliation Data

Dr. Kevin R. Kelly is affiliated with 3 sites of care and 1 medical group

Dr. Kelly's primary practice is USC Norris Cancer Hospital in Los Angeles, California. Dr. Kelly is also affiliated with Los Angeles General Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Kelly to 1 more hospital, named with a free account.

See all 4 affiliations for Dr. Kelly

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Kevin R. Kelly's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelly practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
USC Norris Cancer HospitalAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kelly practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kevin R. Kelly is one of 1,502 hematologists and oncologists in California

Hematology and oncology is Dr. Kelly's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kelly is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kelly's licenses on file in 2 states: California and Texas.

Specialties and state licenses

  • Hematology and oncology, CaliforniaPrimaryLicense A143303 · 2016 to 2027 · taxonomy 207RH0003X
  • Texas licenseLicense 42642 · 2012 to 2026

Clinical focus

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Kelly treats.

Hematologists and oncologists near Dr. Kelly

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kevin R. Kelly billed Medicare for 493 services in 2024

CMS data shows 493 Medicare services from Dr. Kelly across 8 procedure codes in 2024, for 147 Medicare patients. Medicare paid $38,159 for them.

Medicare services, 2024493
Medicare patients147
Paid by Medicare$38,159
Procedure codes8

Dr. Kelly's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6192024: 49320%

Where Dr. Kelly's Medicare services took place, 2024

  • In an office224%
  • In a facility47196%

Dr. Kelly compared with the California median for hematologists and oncologists, 2024

  • Dr. Kelly
  • California median
Medicare services
493vs 93247% below
Medicare patients
147vs 22535% below
Part D claims
132vs 39466% below

Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.

Dr. Kelly's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kelly

Need commercial claims for Dr. Kelly?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kelly and other hematologists and oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kevin R. Kelly treated 147 Medicare patients in 2024, average age 73

CMS counts 147 Medicare patients who saw Dr. Kelly in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelly's median patient age at 66, with 49% women.

Medicare patients, 2024147
Average age73
Average risk score2.83
Also on Medicaid37%

Dr. Kelly's Medicare patients by age, 2024

Dr. Kelly's Medicare patients by sex, 2024

  • Women6141%
  • Men8659%

Chronic conditions among Dr. Kelly's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol72%
  3. Arthritis52%
  4. Ischemic heart disease42%
  5. Chronic kidney disease39%
  6. Diabetes33%
  7. Heart failure28%
  8. Anxiety26%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kelly's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women49%
  • Men51%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kevin R. Kelly wrote 271 Medicare Part D claims in 2024

In 2024, Dr. Kelly wrote 271 Medicare Part D claims for 43 patients. 67% of them were for generic drugs. CMS names the drug for 132 of them, across 6 drugs with 11 or more claims each, at $1,149,005 in total drug cost. In 2023, CMS named 97 claims across 5 drugs.

Part D claims, 2024271
Drugs named by CMS6
Total drug cost$1.1M
Part D patients43

Dr. Kelly's Part D claims by kind of drug, 2024

  • Generic182 claims67%
  • Brand-name and other89 claims33%

Dr. Kelly's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kelly's Part D claims, 2024

  • Antibiotics12%32 of 271 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 972024: 13236%

Drugs named by CMS: 6 in 2024, 5 in 2023.

See all prescribing by Dr. Kelly

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kevin R. Kelly offers telehealth to Medicare patients

Dr. Kelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kelly as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Kelly by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kevin R. Kelly has 26 publications on record

Dmand AI links 26 papers to Dr. Kelly, published from 2012 to 2025. 2015 was the busiest year, with 6. The most frequent topics are Military Personnel and Stress Disorders, Post-Traumatic. Dr. Kelly's most frequent co-authors are Hetty Carraway, MD, Yasuhiro Oki, MD and Mikkael A. Sekeres, MD.

Papers26
Years published2012 to 2025

Dr. Kelly's papers by year, 2014 to 2025

Topics Dr. Kelly writes about most

  • Military Personnel
  • Stress Disorders, Post-Traumatic

Dr. Kelly's most frequent co-authors

Recent publications by Dr. Kelly

See all 26 publications and co-authors

See who Dr. Kelly researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kelly works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kevin R. Kelly has worked on 3 clinical trials

Dmand AI links Dr. Kelly to 3 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Large Granular Lymphocytic, Leukemia, Myeloid, Acute and Lymphoma, Extranodal NK-T-Cell. National Cancer Institute (NCI) sponsors the most, 3.

Clinical trials with Dr. Kelly by phase

  1. 2Phase 1: 2 trials
  2. 1Phase 2: 1 trial
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Kelly's trials

  • Leukemia, Large Granular Lymphocytic
  • Leukemia, Myeloid, Acute
  • Lymphoma, Extranodal NK-T-Cell
  • Immunoblastic Lymphadenopathy
  • Intraocular Lymphoma

Investigators on the most trials with Dr. Kelly

Recent clinical trials with Dr. Kelly

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Kevin R. Kelly received $1,202,628 in industry payments from 2016 to 2025

CMS Open Payments shows 1,163 general payments to Dr. Kelly from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Janssen Pharmaceuticals, Inc paid the most, $346,164. It also lists 14 research payments totaling $9,028 from 2016 to 2024.

General payments to Dr. Kelly by program year, 2016 to 2025

General payments to Dr. Kelly by kind, 2016 to 2025

$1.2Min total
  • Speaker and faculty fees$827,62869%
  • Honoraria$174,51715%
  • Travel and lodging$106,8669%
  • Consulting fees$59,4775%
  • Other$33,8243%

Companies that paid Dr. Kelly the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kelly

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kevin R. Kelly has 1 award and honors on record

Dmand AI lists 1 award for Dr. Kelly, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Kelly

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Kevin R. Kelly graduated from University College Cork Faculty of Medicine

Dr. Kelly graduated from University College Cork Faculty of Medicine in 2001.

  1. Medical schoolUniversity College Cork Faculty of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Kevin R. Kelly accepts plans from 11 insurance carriers

Dr. Kelly is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Blue Cross Blue Shield of Massachusetts
  • HCSC
  • Regence Health Plans
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • +3 more carriersWith a free account

Plan types Dr. Kelly accepts, by number of carriers

  1. Medicare7
  2. PPO7
  3. POS4
  4. HMO3
  5. EPO2
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Kevin R. Kelly's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kevin R. Kelly

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kevin R. Kelly's NPI number?

Dr. Kevin R. Kelly's NPI number is 1093963712. It was assigned on September 6, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Kevin R. Kelly?

Dr. Kevin R. Kelly is a hematologist and oncologist in Los Angeles, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Kevin R. Kelly practice?

Dr. Kelly practices at 1441 Eastlake Ave, Los Angeles, CA. Dr. Kelly's primary practice is USC Norris Cancer Hospital in Los Angeles, California. Dmand AI also links Dr. Kelly to 1 hospital.

What is Dr. Kevin R. Kelly's medical license number?

Dr. Kelly holds California license A143303, one of the licenses on file in 2 states.

Which states has Dr. Kevin R. Kelly been licensed in?

Dmand AI has state licenses on file for Dr. Kelly in California (2016 to 2027) and Texas (2012 to 2026).

Which hospitals is Dr. Kevin R. Kelly affiliated with?

Dr. Kelly is affiliated with Los Angeles General Medical Center. Dmand AI links Dr. Kelly to 1 more hospital.

What medical group is Dr. Kevin R. Kelly part of?

Dr. Kelly is linked to USC Care Medical Group.

Does Dr. Kevin R. Kelly accept Medicare?

Yes. CMS data shows Dr. Kelly billed Medicare for 493 services in 2024, and Dr. Kelly accepts Medicare assignment.

Does Dr. Kevin R. Kelly offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Kelly as offering telehealth services.

How many Medicare patients does Dr. Kevin R. Kelly see?

CMS counts 147 Medicare patients who saw Dr. Kelly in 2024, with an average age of 73.

Show 9 more questionsShow fewer questions

Is Dr. Kevin R. Kelly board certified?

Yes. Dr. Kelly is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Kevin R. Kelly bill to Medicare?

In 2024, Dr. Kelly's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99232) and office visit, established patient (99213).

Where did Dr. Kevin R. Kelly go to medical school?

Dr. Kelly graduated from University College Cork Faculty of Medicine in 2001.

What drugs does Dr. Kevin R. Kelly prescribe most?

In 2024 Medicare Part D data, Dr. Kelly's most prescribed drugs by claims were Acyclovir, Revlimid and Lenalidomide.

Has Dr. Kevin R. Kelly received payments from drug or device companies?

CMS Open Payments shows $1,202,628 in general payments to Dr. Kelly from 34 companies from 2016 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Kevin R. Kelly been practicing?

Dr. Kelly graduated from medical school in 2001, 25 years ago.

Does Dr. Kevin R. Kelly do research?

Dmand AI links 26 publications to Dr. Kelly, published from 2012 to 2025. Dr. Kelly has worked on 3 clinical trials.

Who does Dr. Kevin R. Kelly publish with?

Dr. Kelly's most frequent co-authors are Hetty Carraway, MD (3 shared papers), Yasuhiro Oki, MD (3 shared papers) and Mikkael A. Sekeres, MD (3 shared papers).

What insurance does Dr. Kevin R. Kelly accept?

Dr. Kelly is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)